Compile Data Set for Download or QSAR
maximum 50k data
Found 1836 with Last Name = 'trzoss' and Initial = 'l'
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605909(US11680056, Example 53A | US11680056, Example 53B)
Affinity DataIC50:  0.126nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605939(US11680056, Example 68B)
Affinity DataIC50:  0.200nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605929(US11680056, Example 63B)
Affinity DataIC50:  0.316nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605911(US11680056, Example 54A | US11680056, Example 54B)
Affinity DataIC50:  0.631nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606220(US11685719, Example 8A | US11685719, Example 8B)
Affinity DataIC50:  0.794nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605920(US11680056, Example 59A | US11680056, Example 59B)
Affinity DataIC50:  1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606218(US11685719, Example 23A | US11685719, Example 23B ...)
Affinity DataIC50:  1nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606262(US11685719, Example 28A | US11685719, Example 28B)
Affinity DataIC50:  1nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606246(US11685719, Example 20A | US11685719, Example 20B)
Affinity DataIC50:  1nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606215(US11685719, Example 19A | US11685719, Example 19B ...)
Affinity DataIC50:  1nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606233(US11685719, Example 14B | US11685719, Example 14D)
Affinity DataIC50:  1.26nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605916(US11680056, Example 57A | US11680056, Example 57B)
Affinity DataIC50:  1.26nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605918(US11680056, Example 58A)
Affinity DataIC50:  1.26nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606213(US11685719, Example 21A | US11685719, Example 21B ...)
Affinity DataIC50:  1.26nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605844(US11680056, Example 24A | US11680056, Example 24B)
Affinity DataIC50:  1.58nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605738(US11680056, Example 4 | US11680056, Example 4A | U...)
Affinity DataIC50:  1.58nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606240(US11685719, Example 17A | US11685719, Example 17B)
Affinity DataIC50:  1.58nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606207(US11685719, Example 18A | US11685719, Example 18B ...)
Affinity DataIC50:  1.58nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605926(US11680056, Example 62A)
Affinity DataIC50:  1.58nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605936(US11680056, Example 67A)
Affinity DataIC50:  1.58nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606232(US11685719, Example 14A | US11685719, Example 14C)
Affinity DataIC50:  1.58nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595711(US11591331, Example 22A)
Affinity DataIC50:  1.60nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606213(US11685719, Example 21A | US11685719, Example 21B ...)
Affinity DataIC50:  2nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605930(US11680056, Example 64A | US11680056, Example 64B)
Affinity DataIC50:  2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605914(US11680056, Example 56A | US11680056, Example 56B)
Affinity DataIC50:  2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605897(US11680056, Example 47A | US11680056, Example 47B)
Affinity DataIC50:  2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606207(US11685719, Example 18A | US11685719, Example 18B ...)
Affinity DataIC50:  2nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50:  2nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595709(21 | US11591331, Example 20)
Affinity DataIC50:  2.20nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606258(US11685719, Example 26A | US11685719, Example 26B)
Affinity DataIC50:  2.51nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50:  2.51nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606218(US11685719, Example 23A | US11685719, Example 23B ...)
Affinity DataIC50:  2.51nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606215(US11685719, Example 19A | US11685719, Example 19B ...)
Affinity DataIC50:  2.51nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM631052(US11802128, Example 76)
Affinity DataIC50:  2.80nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605838(US11680056, Example 21A | US11680056, Example 21B)
Affinity DataIC50:  3.16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14/1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM606207(US11685719, Example 18A | US11685719, Example 18B ...)
Affinity DataIC50:  3.16nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605842(US11680056, Example 23A | US11680056, Example 23B)
Affinity DataIC50:  3.16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605924(US11680056, Example 61A | US11680056, Example 61B)
Affinity DataIC50:  3.16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM631042(US11802128, Example 66)
Affinity DataIC50:  3.30nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595782(US11591331, Example 112)
Affinity DataIC50:  3.30nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595688(US11591331, Example 4 | US11591331, Example 93)
Affinity DataIC50:  3.40nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595775(US11591331, Example 105)
Affinity DataIC50:  3.5nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595731(US11591331, Example 53)
Affinity DataIC50:  3.5nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595770(US11591331, Example 100)
Affinity DataIC50:  3.60nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM630952(US11802128, Example 35)
Affinity DataIC50:  3.60nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM631045(US11802128, Example 73)
Affinity DataIC50:  3.60nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595678(US11591331, Example 2)
Affinity DataIC50:  3.60nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM631059(US11802128, Example 80)
Affinity DataIC50:  3.80nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM631058(US11802128, Example 77)
Affinity DataIC50:  3.80nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM595803(US11591331, Example 147)
Affinity DataIC50:  3.80nMAssay Description:Assays based on fluorescent polarization (FP) have been widely utilized in drug discovery due to the homogenous format, robust performance and lack o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1836 total ) | Next | Last >>
Jump to: